Otsuka Holdings
4578.T
#630
Rank
โ‚ฌ30.23 B
Marketcap
53,86ย โ‚ฌ
Share price
0.38%
Change (1 day)
61.03%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Revenue for Otsuka Holdings (4578.T)

Revenue in 2024 (TTM): โ‚ฌ13.41 Billion

According to Otsuka Holdings 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ13.66 Billion. In 2023 the company made a revenue of โ‚ฌ12.84 Billion an increase over the revenue in the year 2022 that were of โ‚ฌ12.14 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Otsuka Holdings from 2010 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ13.41 B4.46%
2023 โ‚ฌ12.84 B5.73%
2022 โ‚ฌ12.14 B2.82%
2021 โ‚ฌ11.81 B8.29%
2020 โ‚ฌ10.90 B-4.62%
2019 โ‚ฌ11.43 B11.74%
2018 โ‚ฌ10.23 B11.22%
2017 โ‚ฌ9.20 B-11.84%
2016 โ‚ฌ10.43 B-4.65%
2015 โ‚ฌ10.94 B
2013 โ‚ฌ10.24 B-5.24%
2012 โ‚ฌ10.81 B-1.9%
2011 โ‚ฌ11.02 B14.97%
2010 โ‚ฌ9.59 B